Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$2.6 - $3.95 $3,928 - $5,968
-1,511 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$3.7 - $4.75 $35,545 - $45,633
-9,607 Reduced 86.41%
1,511 $6,000
Q1 2018

May 15, 2018

SELL
$4.05 - $6.1 $45,598 - $68,679
-11,259 Reduced 50.32%
11,118 $47,000
Q4 2017

Feb 08, 2018

BUY
$2.8 - $5.55 $59,905 - $118,742
21,395 Added 2178.72%
22,377 $125,000
Q3 2017

Nov 14, 2017

BUY
$3.2 - $20.8 $3,142 - $20,425
982
982 $3,000

About OTONOMY, INC.


  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.